- Home
- ETNB vs IAS Comparison
ETNB vs IAS Comparison
Compare ETNB & IAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETNB
- IAS
- Stock Information
- Founded
- ETNB 2018
- IAS 2009
- Country
- ETNB United States
- IAS United States
- Employees
- ETNB N/A
- IAS N/A
- Industry
- ETNB Biotechnology: Pharmaceutical Preparations
- IAS Computer Software: Programming Data Processing
- Sector
- ETNB Health Care
- IAS Technology
- Exchange
- ETNB Nasdaq
- IAS Nasdaq
- Market Cap
- ETNB 1.5B
- IAS 1.5B
- IPO Year
- ETNB 2019
- IAS 2021
- Fundamental
- Price
- ETNB $8.87
- IAS $8.72
- Analyst Decision
- ETNB Strong Buy
- IAS Buy
- Analyst Count
- ETNB 10
- IAS 11
- Target Price
- ETNB $27.22
- IAS $13.55
- AVG Volume (30 Days)
- ETNB 1.5M
- IAS 924.9K
- Earning Date
- ETNB 11-06-2025
- IAS 08-07-2025
- Dividend Yield
- ETNB N/A
- IAS N/A
- EPS Growth
- ETNB N/A
- IAS 3014.55
- EPS
- ETNB N/A
- IAS 0.34
- Revenue
- ETNB N/A
- IAS $569,836,000.00
- Revenue This Year
- ETNB N/A
- IAS $14.77
- Revenue Next Year
- ETNB N/A
- IAS $11.33
- P/E Ratio
- ETNB N/A
- IAS $25.74
- Revenue Growth
- ETNB N/A
- IAS 14.39
- 52 Week Low
- ETNB $4.16
- IAS $6.26
- 52 Week High
- ETNB $11.84
- IAS $13.62
- Technical
- Relative Strength Index (RSI)
- ETNB 43.45
- IAS 48.84
- Support Level
- ETNB $8.46
- IAS $8.62
- Resistance Level
- ETNB $9.47
- IAS $9.09
- Average True Range (ATR)
- ETNB 0.46
- IAS 0.28
- MACD
- ETNB -0.02
- IAS -0.05
- Stochastic Oscillator
- ETNB 33.33
- IAS 17.20
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
About IAS Integral Ad Science Holding Corp.
Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.